Niels Henrik Holländer

机构：Zealand University Hospital · ORCID：0000-0003-2509-2231

发表论文 74 篇 · 总被引 1596 次 · h-index 19

代表论文

• Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer (2021 · Journal of Clinical Oncology · 被引 104)
• Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer (2019 · International Journal of Cancer · 被引 64)
• Phase III randomized clinical trial comparing the efficacy of neoadjuvant chemotherapy and standard treatment in patients with locally advanced colon cancer: The NeoCol trial. (2023 · Journal of Clinical Oncology · 被引 48)
• Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). (2019 · Journal of Clinical Oncology · 被引 41)
• 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT (2019 · Health Technology Assessment · 被引 38)
• Prognostic impact of Charlson’s Age‐Comorbidity Index and other risk factors in patients with pancreatic cancer (2020 · European Journal of Cancer Care · 被引 30)